Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...

Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...

Google DeepMind’s spin-off Isomorphic Labs says it’s almost ready to begin human testing for AI-designed drugs. Built on the ...

Google DeepMind is getting ready to begin human testing of drugs developed using artificial intelligence. All you need to ...

Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...

Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...

One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

3. AlphaFold 3.1. What Is AlphaFold AlphaFold is Alphabet's DeepMind entry in the CASP13 competition. It is an artificial intelligence system designed to tackle the problem of protein folding. A a ...

When it comes to companies shaping the future of AI, one of the first to come to mind is Google's parent company, Alphabet ( ...

Beware the tech leaders making grandiose statements about artificial intelligence. They have lost sight of reality, says ...

European technology companies are commanding attention on the global stage, with several securing massive funding rounds that ...